EnClear Therapies Competitors and Similar CompaniesClear all

EnClear Therapies's competitors and similar companies include CHF Solutions, Spero Therapeutics, MicrofluidX and Tactile Medical.

	EnClear Therapies EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.	CHF Solutions CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.	Spero Therapeutics Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections.	MicrofluidX MicrofluidX is a company that develops cell bioprocessing technology.	Tactile Medical Tactile Medical is advancing the standard of care in treating chronic diseases at home.
Founding Date	Founding Date 2018	Founding Date 1999	Founding Date 2013	Founding Date 2018	Founding Date 2006
Type	Type Private	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech healthtech medical devices therapy	Tags Healthcare biotech healthtech medical devices therapy	Tags Healthcare biotech healthtech medical devices therapy	Tags Healthcare biotech genetics healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy
Locations	Locations Newburyport, US HQ	Locations Eden Prairie, US HQ	Locations Cambridge, US HQ	Locations HQ	Locations Minneapolis, US HQ
Employees	Employees 11	Employees 6620% increase	Employees 5739% increase	Employees 405% decrease	Employees 62926% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 34.5 m	Valuation ($) 70.8 m	Valuation ($) N/A	Valuation ($) 346.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $8.3m (FY, 2025)	Revenue (est.) $66.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $329.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $3.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $79.4m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $5.1m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $250.1m (FY, 2025)
Net income	Net income N/A	Net income ($17.5m) (FY, 2025)	Net income $8.6m (FY, 2025)	Net income N/A	Net income $19.1m (FY, 2025)
Funding
Latest funding round	Latest funding round $ 10m (over 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 1.7m (about 6 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 12m	Total funding raised $ 9m	Total funding raised $ 121.5m	Total funding raised $ 1.7m	Total funding raised $ 23.2m